Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.15M.
ENTERPRISE VALUE (EV)
$2.15M
Curanex Pharmaceuticals Inc Common Stock
Market Cap
$6.90M
Enterprise Value (EV)
$2.15M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Curanex Pharmaceuticals Inc Common Stock (CURX) | $6.90M | $2.15M |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.94M | $15.70M |
| KALA BIO, Inc. (KALA)vs › | $7.07M | $6.84M |
| Exicure, Inc. (XCUR)vs › | $7.08M | $5.36M |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.08M | $7.08M |
| Aclarion, Inc. (ACON)vs › | $6.72M | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.13M | $7.22M |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | $5.28M |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.61M | $6.13M |
| Longeveron Inc. (LGVN)vs › | $7.21M | N/A |
Market Cap
$6.90M
Total Debt
$224010.00
Cash
$4.97M
Enterprise Value
$2.15M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
